From September 1, 2022 to November 30, 2022, the company has repurchased 344,837 shares, representing 1.24% for KRW 1,526.31 million. With this, the company has completed the repurchase of 344,837 shares, representing 1.24% for KRW 1,526.31 million under the buyback announced on June 23, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,785 KRW | -0.26% | -0.39% | -7.91% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-7.91% | 77.33M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- A004310 Stock
- News Hyundai Pharmaceutical Co., Ltd.
- Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.